Finally, to evaluate the clinical significance of MIF, CXCR4 and VMs in glioma, overall survival was analyzed by stratifying patients according to the immunochemistry score for MIF and CXCR4 or VM-positive (Figure 2C). The gene discussed is CXCR4; the disease is central nervous system cancer.